Maraviroc inhibits SARS-CoV-2 multiplication and s-protein mediated cell fusion in cell culture
K. Risner, K. V. Tieu, Y. Wang, M. Getz, A. Bakovic, N. Bhalla, S. Nathan, D. E. Conway, P. Macklin, A. Narayanan
This study identifies four FDA-approved drugs that inhibit SARS-CoV-2 infection in cell culture, with Maraviroc showing reduced S-protein mediated cell fusion.
bioRxiv · Aug 12, 2020 · PreprintMicrobiology